Partnerships

Mogrify is looking to partner with disruptive innovators in the fields of regenerative medicine, in vivo reprogramming, and other cell-based therapies to develop treatments for indications of high unmet clinical need. We are particularly interested in speaking with those with interest in otology, ophthalmology, and diabetes, as well as other disease areas where these modalities may be of interest. Mogrify is commercializing its technology via a combination of in vivo reprogramming therapy development, co-development partnerships, as well as the exploitation of the platform in other therapeutic and non-therapeutic applications.